Your institution may have access to this item. Find your institution then sign in to continue.

Title: First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.
Authors: Berlin, Jordan; Tolcher, Anthony W.; Ding, Cliff; Whisenant, Jennifer G.; Horak, Ivan D.; Wood, Debra L.; Nadler, Paul I.; Hansen, Ulla Holm; Lantto, Johan; Skartved, Niels Jørgen Ø.; Pedersen, Mikkel W.; Patnaik, Amita
Publication: Investigational New Drugs, 2022, Vol 40, Issue 3, p586
ISSN: 0167-6997
Publication type: Academic Journal
DOI: 10.1007/s10637-022-01217-7

We found a match

First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.